However, additional research is needed to fully understand the mechanisms by which the putative oncochannels TRPV6 and TRPV2 may influence cancer progression and to explore the potential of pharmacological modulation – whether activation or inhibition – as a therapeutic strategy for controlling tumor growth and metastasis in specific cancer types. This evidence concerns the gene TRPV2 and neoplasm.